NDC 61825-302 Orphengesic Forte
Orphenadrine Citrate,Aspirin And Caffeine Tablet Oral - View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 61825 - Galt Pharmaceuticals, Llc
- 61825-302 - Orphengesic Forte
Product Characteristics
Product Packages
NDC Code 61825-302-60
Package Description: 60 TABLET in 1 BOTTLE, PLASTIC
Product Details
What is NDC 61825-302?
What are the uses for Orphengesic Forte?
What are Orphengesic Forte Active Ingredients?
- ASPIRIN 770 mg/1 - The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
- CAFFEINE 60 mg/1 - A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling.
- ORPHENADRINE CITRATE 50 mg/1 - A muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm.
Which are Orphengesic Forte UNII Codes?
The UNII codes for the active ingredients in this product are:
- ORPHENADRINE CITRATE (UNII: X0A40N8I4S)
- ORPHENADRINE (UNII: AL805O9OG9) (Active Moiety)
- ASPIRIN (UNII: R16CO5Y76E)
- ASPIRIN (UNII: R16CO5Y76E) (Active Moiety)
- CAFFEINE (UNII: 3G6A5W338E)
- CAFFEINE (UNII: 3G6A5W338E) (Active Moiety)
Which are Orphengesic Forte Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ANHYDROUS LACTOSE (UNII: 3SY5LH9PMK)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)
- FD&C BLUE NO. 1 (UNII: H3R47K3TBD)
- ZINC STEARATE (UNII: H92E6QA4FV)
- POVIDONE (UNII: FZ989GH94E)
- STARCH, CORN (UNII: O8232NY3SJ)
- STEARIC ACID (UNII: 4ELV7Z65AP)
- WATER (UNII: 059QF0KO0R)
What is the NDC to RxNorm Crosswalk for Orphengesic Forte?
- RxCUI: 994535 - orphenadrine citrate 50 MG / aspirin 770 MG / caffeine 60 MG Oral Tablet
- RxCUI: 994535 - aspirin 770 MG / caffeine 60 MG / orphenadrine citrate 50 MG Oral Tablet
- RxCUI: 994535 - ASA 770 MG / caffeine 60 MG / orphenadrine citrate 50 MG Oral Tablet
- RxCUI: 994539 - ORPHENGESIC FORTE 50 MG / 770 MG / 60 MG Oral Tablet
- RxCUI: 994539 - aspirin 770 MG / caffeine 60 MG / orphenadrine citrate 50 MG Oral Tablet [Orphengesic]
Which are the Pharmacologic Classes for Orphengesic Forte?
- Anti-Inflammatory Agents, Non-Steroidal - [CS]
- Central Nervous System Stimulant - [EPC] (Established Pharmacologic Class)
- Central Nervous System Stimulation - [PE] (Physiologic Effect)
- Centrally-mediated Muscle Relaxation - [PE] (Physiologic Effect)
- Cyclooxygenase Inhibitors - [MoA] (Mechanism of Action)
- Decreased Platelet Aggregation - [PE] (Physiologic Effect)
- Decreased Prostaglandin Production - [PE] (Physiologic Effect)
- Methylxanthine - [EPC] (Established Pharmacologic Class)
- Muscle Relaxant - [EPC] (Established Pharmacologic Class)
- Nonsteroidal Anti-inflammatory Drug - [EPC] (Established Pharmacologic Class)
- Platelet Aggregation Inhibitor - [EPC] (Established Pharmacologic Class)
- Xanthines - [CS]
* Please review the disclaimer below.
[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".